<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tshilenge KT</submitter><funding>NIA NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>100534</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10165459</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(5)</volume><pubmed_abstract>Huntington's disease (HD) is a neurodegenerative disease caused by a CAG repeat expansion in the Huntingtin (HTT) gene. The resulting polyglutamine (polyQ) tract alters the function of the HTT protein. Although HTT is expressed in different tissues, the medium-spiny projection neurons (MSNs) in the striatum are particularly vulnerable in HD. Thus, we sought to define the proteome of human HD patient-derived MSNs. We differentiated HD72-induced pluripotent stem cells and isogenic controls into MSNs and carried out quantitative proteomic analysis. Using data-dependent acquisitions with FAIMS for label-free quantification on the Orbitrap Lumos mass spectrometer, we identified 6323 proteins with at least two unique peptides. Of these, 901 proteins were altered significantly more in the HD72-MS</pubmed_abstract><journal>Molecular &amp; cellular proteomics : MCP</journal><pubmed_title>Proteomic Analysis of Huntington's Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets.</pubmed_title><pmcid>PMC10165459</pmcid><funding_grant_id>R01-NS100529</funding_grant_id><funding_grant_id>S10 OD016281</funding_grant_id><funding_grant_id>R01 NS100529</funding_grant_id><funding_grant_id>1S10 OD016281</funding_grant_id><funding_grant_id>S10 OD028654</funding_grant_id><funding_grant_id>K99 AG065484</funding_grant_id><pubmed_authors>Loureiro A</pubmed_authors><pubmed_authors>Battistoni E</pubmed_authors><pubmed_authors>Hetz C</pubmed_authors><pubmed_authors>Rose J</pubmed_authors><pubmed_authors>Tshilenge KT</pubmed_authors><pubmed_authors>Milani M</pubmed_authors><pubmed_authors>Naphade S</pubmed_authors><pubmed_authors>Wehrfritz C</pubmed_authors><pubmed_authors>Basisty N</pubmed_authors><pubmed_authors>Schilling B</pubmed_authors><pubmed_authors>Bons J</pubmed_authors><pubmed_authors>Lopez-Ramirez A</pubmed_authors><pubmed_authors>Gerencser AA</pubmed_authors><pubmed_authors>Song S</pubmed_authors><pubmed_authors>Aguirre CG</pubmed_authors><pubmed_authors>Mooney SD</pubmed_authors><pubmed_authors>Ellerby LM</pubmed_authors><pubmed_authors>Holtz A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proteomic Analysis of Huntington's Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets.</name><description>Huntington's disease (HD) is a neurodegenerative disease caused by a CAG repeat expansion in the Huntingtin (HTT) gene. The resulting polyglutamine (polyQ) tract alters the function of the HTT protein. Although HTT is expressed in different tissues, the medium-spiny projection neurons (MSNs) in the striatum are particularly vulnerable in HD. Thus, we sought to define the proteome of human HD patient-derived MSNs. We differentiated HD72-induced pluripotent stem cells and isogenic controls into MSNs and carried out quantitative proteomic analysis. Using data-dependent acquisitions with FAIMS for label-free quantification on the Orbitrap Lumos mass spectrometer, we identified 6323 proteins with at least two unique peptides. Of these, 901 proteins were altered significantly more in the HD72-MS</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-07-14T20:07:38.747Z</modification><creation>2025-04-06T14:37:29.319Z</creation></dates><accession>S-EPMC10165459</accession><cross_references><pubmed>36958627</pubmed><doi>10.1016/j.mcpro.2023.100534</doi></cross_references></HashMap>